Recruiting studies: Netherton Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
Phase 1 · 2 location(s) · Azitra Inc. · NCT06137157 A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
Phase 1 · 12 location(s) · BioCryst Pharmaceuticals · NCT06539507 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Phase 2/Phase 3 · 1 location(s) · Quoin Pharmaceuticals · NCT06953466 Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Phase 2/Phase 3 · 4 location(s) · Quoin Pharmaceuticals · NCT05789056 Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07280091 Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Phase 2/Phase 3 · 5 location(s) · Quoin Pharmaceuticals · NCT07538583

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.